About NanoString® Technologies, Inc.
NanoString Technologies is a leading provider of life science tools for translational research. The company’s nCounter® Analysis System is used in life sciences research and has been cited in more than 3,200 peer-reviewed publications. The nCounter® Analysis System offers a cost-effective way to easily profile the expression of hundreds of genes, proteins, miRNAs, or copy number variations, simultaneously with high sensitivity and precision, facilitating a wide variety of basic research and translational medicine applications, including biomarker discovery and validation. The company’s GeoMx™ Digital Spatial Profiler enables highly-multiplexed spatial profiling of RNA and protein targets in a variety of sample types, including FFPE tissue sections. For more information, please visit www.nanostring.com.
Europe - 9:00 AM Central European Time
Americas - 9:00 AM Central Standard Time
Asia-Pacific - 9:00 AM Beijing Standard Time (*February 24)
Spatial Genomics is accelerating discoveries in research with new advancements arriving every day! It’s time to get on board with this exciting, dynamic and rapidly evolving spatial technology.
Join NanoString and leaders in this field at the Third Annual Spatial Genomics Summit, a Pre-AGBT tradition. We welcome everyone to join us in the virtual world for an exciting journey through spatial genomics with a keynote panel of academic and industry leaders, an exciting selection of Rapid Application Presentations (RAP) and an exploration of the power and sensitivity of spatial genomics data! Finally, Joseph Beechem, NanoString’s Chief Scientific Officer and Vice President of R&D, will share notable technology developments in spatial genomics and single molecule imaging.
NanoString will host the summit from our NEW GeoMx® Experience Lab, at our headquarters in Seattle, Washington and provide a “hands on” tour of running a spatial genomics project.
Don’t miss this opportunity to see exciting speakers, scientific advancements and new technology, REGISTER TODAY!
Partner at DeciBio
Scientific Market Development Director of BioPharma, Nanostring
Appointed Cellular Genetics Group Leader, Wellcome Sanger Institute
Associate Professor, Vaccine and Infectious Disease Division, Fred Hutch
Otto Krayer Professor of Systems Biology, Harvard Medical School
Erasmus University Medical Center
NHMRC Research Fellow, The University of Queensland
Instructor, Department of Pharmacology Siriraj Laboratory for Systems Pharmacology Faculty of Medicine, Siriraj Hospital Mahidol University
MRC Clinical Research Training Fellow, UCL (University College London)
Associate Professor of Medicine, Nephrology, Icahn School of Medicine at Mount Sinai
CHIEF SCIENTIFIC OFFICER AND Senior Vice President Of Research and Development, NANOSTRING TECHNOLOGIES